Matthew S. Cernobyl, MBA, Pmp, Bsbc
About Matthew S. Cernobyl, MBA, Pmp, Bsbc
Matthew S. Cernobyl, MBA, PMP, BSBC, is a Senior Manager at Bristol-Myers Squibb and the Founder of Matthieu's LLC.
Title and Role
Matthew S. Cernobyl serves as the Senior Manager for Biologics CMC Document Management, Global Capabilities & Technical Strategy at Bristol-Myers Squibb. In this role, he is responsible for leading cross-functional teams that author and review CMC regulatory submissions to global health authorities. He is also involved in managing submissions for both commercial and development assets within the biologics portfolio.
Education and Expertise
Matthew S. Cernobyl has a distinguished academic background. He studied at DeSales University, where he earned a Master of Business Administration in Program Management with Highest Honors. He also holds a Bachelor of Science in Biochemistry with Honors from Lehigh University. His areas of expertise include CMC regulatory submissions, document compliance, and controls (GMP/GLP), and project management.
Professional Background
Matthew S. Cernobyl has an extensive professional history in the pharmaceutical and biotechnology industry. Before his current role, he worked as Lead, Document Compliance & Controls (GMP/GLP) at Bristol-Myers Squibb from 2010 to 2013. He also held positions at Medarex as a Senior CMC Regulatory Specialist and CMC Regulatory Specialist in 2010 for 11 months. Additionally, he founded Level Therapeutics in Bethlehem, PA, in 2010.
Entrepreneurial Ventures
In addition to his role at Bristol-Myers Squibb, Matthew S. Cernobyl is also the Founder and Entrepreneur of Matthieu's LLC, located in Lehigh Valley, PA. He has demonstrated his ability to manage and lead within both corporate and entrepreneurial environments.
Work Locations and Responsibilities
Matthew S. Cernobyl operates across multiple locations, including New Brunswick, Hopewell, and Bloomsbury in New Jersey. At Bristol-Myers Squibb, he is crucial in preparing and responding to queries and preparing briefing packages for global health authorities, ensuring compliance and facilitating effective communication in regulatory submissions.